Editorial
For those health care providers fortunate to care for patients with significant cardiovascular disease, whether it is in the intensive care unit, the operating room, in need of a transplant, or otherwise, the field continues to evolve as understanding of various disease states progresses leading to improvements in treatment modalities and surgical options for our patients. This also means that we each have to keep pace with not only the huge breadth of existing knowledge but continually focus on the cutting-edge information available to offer the best care for our patients. Patients with cardiovascular disease are a particularly difficult group as medical care has enabled patients to survive longer, with more severe cardiac disease. This keeps pushing the boundaries of what we can offer from both surgery and anesthesiology perspectives in the cardiac operating room and general operating room. It is with this in mind that we select our content for each issue of Seminars in Cardiothoracic and Vascular Anesthesia (SCVA), attempting to blend a mix of clinically relevant articles along with cutting-edge information on the best perioperative care for these patients. The December issue is a great example of this as we have a wide range of articles including review articles covering Takotsubo cardiomyopathy, interventions in the interventional cardiology suite for both lead extractions and atrial appendage occlusion device placement, management of patients with hemophilia undergoing cardiac surgery, and finally a review on finger-type hemodynamic monitors. The Congenital Cardiac Forum includes a pair of articles on dexmedetomidine use in the cardiac catheterization laboratory. Our Transplant Forum highlights 2 articles, the first is a position paper from the Society for Advancement of Transplant Anesthesia regarding fellowship training in transplant anesthesia and the second is a case-matching study looking at the outcomes of patients requiring aortic valve interventions following liver transplantation. Finally, we have a series of clinical challenges, two of which discuss specific airway management challenges related to airway surgery, along with a unique report of aortic valve stenosis due to alkaptonuric ochronosis.
Takotsubo cardiomyopathy was initially described in the 1990s as a syndrome that mimics acute myocardial infarction; however, there is an absence of obstructive disease. 1 It is known by many names including stress cardiomyopathy, broken heart syndrome, apical ballooning, but Takotsubo cardiomyopathy seems to be the accepted nomenclature. This was coined after the Japanese term for an octopus trap, which resembles the shape of the affected left ventricle in systole in patients with this process. 2 Takotsubo cardiomyopathy is relatively rare, but often happens in a stress-induced scenario and frequently in a younger population; thus, when it occurs it is very dramatic. In their article "Perioperative Takotsubo Cardiomyopathy: A Systematic Review of Published Cases," Dr Agarwal and colleagues conducted a systematic review of currently published cases of perioperative Takotsubo cardiomyopathy, which includes analysis of 93 articles, with a subsequent analysis of 102 cases. 3 These were then compared with the International Takotsubo Registry results for nonperioperative cases. The authors were able to identify differences in perioperative versus non-perioperative Takotsubo patients, namely, age of onset and lower likelihood of ST segment changes on electrocardiogram. The article does an excellent job of pooling known data on this rare group of patients with this condition, and the authors provide a great overview of the condition as well as provide management recommendations for the readers to utilize.
The field of interventional cardiology is continually making advances, often by leaps and bounds, so it is not surprising that this field has a continuous presence in SCVA. One area that represents a growing percentage of cases in the hybrid operating room or interventional suite is lead extractions for patients with cardiovascular implantable electronic devices, whether due to malfunction, infection, or breakage of the leads. Despite the introduction of the new leadless pacemakers, there have been so many leads implanted in the past 20 years that this will be a continual issue for years to come. One big concern for anesthesiologists taking care of these patients is the lack of standardized guidance regarding risk stratification, recommended involvement of cardiac surgeons and perfusionists, as well as need for cardiac anesthesiologist coverage. In their article, "Anesthetic Management of Laser Lead Extraction for Cardiovascular Implantable Electronic Devices," Dr Bahtia and colleagues have done an excellent job of summarizing the indications for lead extraction, the rationale in decision making that the cardiologist or surgeon uses, and in presenting a recommended anesthetic management plan for these cases. 4 Atrial exclusion techniques are also a relatively new addition to the interventional suite and present an option for managing patients with atrial fibrillation who are unable to tolerate anticoagulation medications and have failed ablation therapy. In their article, "Anesthetic Management of Patients Undergoing Percutaneous Endocardial and Epicardial Left Atrial Appendage Occlusion," Dr Husain and colleagues have presented the background for the development of these devices, as well as detailed information on the 2 most common procedures, namely, the Watchman and the Lariat. 5 This article provides a comprehensive description including key anesthetic considerations for these procedures, as well as postoperative management considerations.
Rounding out the general review section for this issue we present a fantastic case-based review focused on management of the hemophiliac patient having cardiac surgery. 6 The authors discuss the case management of a patient with hemophilia to lay the groundwork for the discussion of the effects of cardiopulmonary bypass on Factor VIII, recommendations on laboratory testing for these cases, as well as a coagulation management approach to this case. The final review article is a technology-based review written by Raggia and Sakai titled "Update on Finger-Application-Type Noninvasive Continuous Hemodynamic Monitors (CNAP and ccNexfin): Physical Principles, Validation, and Clinical Use." 7 In this article, the authors go into detail on the principles behind two of the new finger applications monitors that are capable of both blood pressure monitoring as well as continuous cardiac output monitoring. They provide the readers with an understanding of the principles behind these 2 devices, which leads to an understanding of their limitations, which tends to be in those patients on high doses of vasoconstrictors.
In this issue, the Congenital Cardiac Forum has 2 articles about the use of dexmedetomidine in the cardiac catheterization laboratory. The use of dexmedetomidine is increasing in pediatric cardiac anesthesia practice. 8 The attractions of dexmedetomidine are that it is a potent α-2 receptor agonist, which produces sedation and analgesia with minimal respiratory depression, and it may have neuroprotective properties compared with many other anesthetic agents, which are possibly neurotoxic. In this issue, Riveros and colleagues examine the hemodynamic properties of dexmedetomidine and whether it is a useful drug to prevent emergence agitation in children following cardiac catheterization. 9 They report a single-center, retrospective, case-matched study of 662 children and find that dexmedetomidine use is not associated with any more or less hemodynamic stability compared with children receiving other anesthetic agents. They also show that there is no difference in the incidence of postprocedure agitation. These results are both surprising and reassuring. It is surprising that there was no significant difference in the hemodynamic changes between dexmedetomidine and other anesthetic agents as dexmedetomidine is known to cause an increase in systemic vascular resistance and blood pressure, although these effects are transient and dose-dependent following a loading dose. It is also widely thought that dexmedetomidine may reduce emergence agitation in children following procedures. However, these results are also somewhat reassuring that dexmedetomidine is likely no better, or worse, than any other anesthetic agent we use. What Riveros and colleagues were not able to assess are exactly how these anesthetic drugs are being used-anesthesia is both a science and an art, and drugs may have different effects depending on a practitioner's techniques. In the second article, Friesen and colleagues examine the hemodynamic responses to dexmedetomidine and propose that the different responses seen between patients is due to adrenoreceptor variance. 10 This elegant study showed that there was no difference among genotype groups and the vasoconstrictor response to dexmedetomidine. Again, while the science is sound and the hypothesis attractive, much of the variability in response to anesthetic medications is not just due to the difference between patients, but the variability in the techniques of the anesthesia practitioner.
Anesthesia management for liver transplantation has become exceedingly complex due to an increasing number of recipients with advanced liver failure with multiple comorbidities. Ad hoc anesthesia training based on a tacit institutional protocol may not sufficiently equip anesthesiologists and trainees for such challenging cases. To best serve these patients who seek liver transplantation as the final means for their morbid condition, it is the professional responsibility for leaders of transplant anesthesiology community to build a structure fellowship training program for liver transplantation. For the December issue of SCVA, a white paper proposal for a structured liver transplant anesthesia fellowship program is featured. 11 This is the official proposal from the Society for the Advancement of Transplant Anesthesia outlining a detailed educational training plan for transplant fellowship training and serves as a sounding board for educators in the transplant anesthesiology and critical care medicine community. The second article in this section is a case-matching study that looks at cardiac morbidity and mortality in patients who have had liver transplantation and go on to develop aortic valve disease requiring surgical intervention. 12 This is a well-done look at a unique clinical question that provides some perspective on patients who have survived liver transplant and are now presenting to the cardiac room.
Completing our our December issue is a collection of clinical challenges articles describing some unique conditions. The first 2 articles are based around unique clinical scenarios involving the airway. Dr Ghaffaripour and colleagues provide a unique case description for repair of acquired tracheoesophageal fistula using an endoscopic approach with a focus on the anesthetic management considerations. 13 The second also discusses anesthetic management but for a different problem that involves tracheal dehiscence following tracheal resection. This excellent article highlights some of the critical management details for this life-threatening condition. 14 The last article for this month's issue is a surgical article describing a unique and rare etiology of aortic valve stenosis. The authors present the surgical case for this patient that was found to have alkaptonurin ochronosis and present very unique descriptive findings at surgery as well as the pathologic basis of the disease. 15 In our December issue of the SCVA, we have compiled contemporary articles on perioperative noninvasive hemodynamic monitoring, on management of patients presenting with different preexisting heart conditions undergoing cardiac surgery or related procedures, on dexmedetomidine use in pediatric cardiac catheterization procedures, and genetically driven variability in dexmedetomidine response in pediatric patients. With the overarching goal of SCVA to support the mission of the Society for the Advancement of Transplant Anesthesia, our journal is also publishing a white paper advocating measurable proficiency in training of future to be fellows in liver transplant anesthesia, which we sincerely hope will serve as an initial process for our journal to become a leader in facilitating the improvement of perioperative management of patients undergoing liver transplantation. To continue with our formal tradition, our December issue is concluded with a set of clinically challenging cases to guide our readers on the assessment and management of complex patients presenting for cardiothoracic procedures. Thus, with the current issue of the SCVA we hope to continue to guide care providers with the perioperative assessment and management of these complex cardiothoracic adult and pediatric patients, as well as solid organ transplant recipients.
